Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Duration of Dual Anti-Platelet Therapy in Chronic Limb Threatening Ischemia After Distal Revascularization: a Randomized, Double-blind Trial PALADIN [PeripherAL Arterial DIsease Network] -DAPTCLTI

NCT07512960 is registered in ClinicalTrials.gov with Fondation Hôpital Saint-Joseph as lead sponsor.

NCT NCT07512960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07512960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Duration of Dual Anti-Platelet Therapy in Chronic Limb Threatening Ischemia After Distal Revascularization: a Randomized, Double-blind Trial PALADIN [PeripherAL Arterial DIsease Network] -DAPTCLTI
Lead sponsor
Fondation Hôpital Saint-Joseph
Phase
Phase 3
Overall status
Recruiting
Start date
June 12, 2026
Completion date
November 30, 2030
Enrollment
614 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clti defined as rutherford category 4 or 5